Pharmacological modification of multi‐drug resistance (mdr) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin a and verapamil on mdr leukemia t‐cells

International Journal of Cancer

Volumn 46, Issue 1, 1990, Pages 67-72

  Larsson, Rolf ^a   Nygren, Peter ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DILTIAZEM; VERAPAMIL;

ARTICLE; CELL CULTURE; DRUG RESISTANCE; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

BENZIMIDAZOLES; CELL DIVISION; CELL LINE; CELL SURVIVAL; COMPARATIVE STUDY; CYCLOSPORINS; CYTOLOGICAL TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG SCREENING ASSAYS, ANTITUMOR; FLUORESCEINS; FLUORESCENT DYES; FLUOROMETRY; HUMAN; LEUKEMIA, LYMPHOCYTIC, ACUTE; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; VERAPAMIL; VINCRISTINE;

EID: 0025280767     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910460114     Document Type: Article

References (36)

1. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay
2. The cell biology of multidrug resistance
3. Treatment of children with refractory acute lymphocytic leukemia with vincristine and diltiazem
4. Action of calcium antagonists on multidrug resistant cells: specific cytotoxicity independent of increased cancer drug accumulation
5. Evaluation of a tetrazolium‐based semiautomated colorimetric assay: assessment of chemosensitivity testing
6. Doxorubicin cytotoxicity enhanced by local anesthetics in a human melanoma cell line
7. Use of DiO‐C5‐3 to improve Hoechst 33342 uptake, resolution of DNA content, and survival of CHO cells
8. Drug resistance in multiple myeloma and non‐Hodgkin's lymphoma: detection of P‐glycoprotein and potential circumvention by addition of verapamil to chemotherapy
9. Antiproliferative activity of cyclosporin A on human T‐lymphoblastic leukemia cell line
10. Enhancement of sensitivity to adriamycin in resistant P3888 leukemia by the calmodulin inhibitor trifluoperazine
11. Homology between Pglycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance
12. A surface glycoprotein modulating drug permeability in Chinese hamster ovary mutants
13. Pharmacokinetics of cyclosporine in human renal transplantation
14. A semiautomated fluorometric method for determination of cytotoxicity and cellular proliferation of human tumor cell lines in microculture
15. Reduced permeability in CHO cells as a mechanism of resistance to colchicine
16. Clinical modulation of doxorubicin resistance by the calmodulin‐inhibitor, trifluoperazine: a phase I/II trial
17. Mechanisms and clinical significance of multidrug resistance
18. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
19. Use of fluorescent dyes as molecular probes for the study of multidrug resistance
20. Recent advances in the biochemistry of polyamines in eukaryotes
21. Restoration of doxorubicin responsiveness in doxorubicin resistant P388 murine leukaemia cells
22. Reversal of adriamycin resistance by verapamil in human ovarian cancer
23. Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multidrug resistance
24. Antiproliferative effect of verapamil alone on brain tumor cellsin vitro
25. Verapamil potentiation of VP‐16‐213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance
26. Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphocyte leukemia in vitro
27. Cyclosporin A is selectively cytotoxic to human leukemic T cellsin vitro
28. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vcr and adriamycin in drug resistant tumor cells
29. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
30. A possible role for cyclosporins in cancer chemotherapy
31. Modifications of cytotoxic drug resistance by nonimmunosuppressive cyclosporins
32. Cyclosporin A and its analogues as modifiers of adriamycin and vcr resistance in multidrug resistant human lung cancer cell line
33. Properties of verapamil hypersensitive multidrug‐resistant Chinese hamster ovary cells
34. Comparison of dye exclusion assays with a clonogenic assay in the determination of drug induced cytotoxicity
35. On the potential role of cyclosporin in the treatment of lymphoproliferative diseases